Asciminib: High Responses in Second-Line Chronic-Phase CML ...Middle East

Medscape - News
Asciminib: High Responses in Second-Line Chronic-Phase CML
In interim analysis of phase 2 ASC2ESCALATE trial, patients with chronic-phase chronic myeloid leukemia who fail to respond to first-line therapies show major molecular responses to asciminib. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Asciminib: High Responses in Second-Line Chronic-Phase CML )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News